Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Conditions

Neoplasms 5Colorectal Neoplasms, Hereditary Nonpolyposis 3Colorectal Neoplasms 3Sarcoma 2Recurrence 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Stage IIIb and IV Non Small Cell Lung Cancer 1Solid Tumor, Adult 1Rare Diseases 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Neoplastic Syndromes, Hereditary 1Neoplasm, Residual 1Neoplasm Metastasis 1Multiple Myeloma 1Mouth Neoplasms 1Microsatellite Instability 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hereditary Breast and Ovarian Cancer Syndrome 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Medullary 1COVID-19 1Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 153Dexamethasone 141Rituximab 85fludarabine 79Lenalidomide 72Cytarabine 70Bortezomib 64fludarabine phosphate 63Gemcitabine 62venetoclax 54Etoposide 53pomalidomide 52pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × High-Throughput Nucleotide Sequencing × Clear all
NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Recruiting
3,500 enrolled

Neoplasms, Recurrence

NCT05483257 2022-08-02

Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma

Ruijin Hospital

Completed
226 enrolled

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡